• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用血管紧张素II 1型受体抑制剂依普罗沙坦进行抗高血压治疗导致的乳糜泻样肠病。

Celiac disease-like enteropathy due to antihypertensive therapy with the angiotensin-II receptor type 1 inhibitor eprosartan.

作者信息

Maier Hans, Hehemann Karlheinz, Vieth Michael

出版信息

Cesk Patol. 2015;51(2):87-8.

PMID:25970720
Abstract

An 83-year-old woman with hypertension received the angiotensin-II receptor type 1 blocker (ARB) eprosartan for more than 10 years. Six months ago, the dosage of the drug was doubled, and the patient reported a sudden onset of diarrhea. Duodenal biopsies showed a celiac disease-like pathology with flattened mucosa and an increase of intraepithelial lymphocytes and eosinophils, but serology of celiac disease remained negative. Celiac disease-like changes have been previously reported to be associated with other ARBs. This is the first case following eprosartan medication. In celiac-disease-like pathology of the small bowel with negative serology, drug-induced changes, for example due to ARBs, should be excluded.

摘要

一位83岁的高血压女性服用血管紧张素II 1型受体阻滞剂(ARB)依普罗沙坦超过10年。6个月前,该药剂量加倍,患者报告突然出现腹泻。十二指肠活检显示有乳糜泻样病理改变,黏膜扁平,上皮内淋巴细胞和嗜酸性粒细胞增多,但乳糜泻血清学检查仍为阴性。此前有报道称,乳糜泻样改变与其他ARB有关。这是服用依普罗沙坦后的首例病例。在血清学检查阴性的小肠乳糜泻样病理改变中,应排除药物引起的改变,例如由ARB引起的改变。

相似文献

1
Celiac disease-like enteropathy due to antihypertensive therapy with the angiotensin-II receptor type 1 inhibitor eprosartan.使用血管紧张素II 1型受体抑制剂依普罗沙坦进行抗高血压治疗导致的乳糜泻样肠病。
Cesk Patol. 2015;51(2):87-8.
2
Angiotensin blockade with eprosartan: vascular and functional implications.依普罗沙坦的血管紧张素阻断作用:对血管及功能的影响
Curr Med Res Opin. 2007 Nov;23 Suppl 5:S5-11. doi: 10.1185/030079907X260700.
3
Effects of eprosartan on diastolic function and neurohormones in patients with hypertension and diastolic dysfunction.厄贝沙坦对高血压并舒张功能障碍患者舒张功能及神经激素的影响。
Cardiovasc Drugs Ther. 2010 Feb;24(1):33-40. doi: 10.1007/s10557-010-6221-4.
4
Antihypertensive effects and safety of eprosartan: a meta-analysis of randomized controlled trials.依普罗沙坦的降压效果和安全性:一项随机对照试验的荟萃分析。
Eur J Clin Pharmacol. 2012 Feb;68(2):195-205. doi: 10.1007/s00228-011-1107-3. Epub 2011 Sep 1.
5
Angiotensin receptor blockers and secondary stroke prevention: the MOSES study.血管紧张素受体阻滞剂与继发性卒中预防:MOSES研究
Expert Rev Cardiovasc Ther. 2009 May;7(5):459-64. doi: 10.1586/erc.09.3.
6
Eprosartan dual action offers clinical benefit for elderly and overweight hypertensives.依普罗沙坦的双重作用为老年和超重高血压患者带来临床益处。
Cardiovasc J S Afr. 2004 Mar-Apr;15(2):91-2.
7
Introduction: The pharmacological profile of eprosartan--implications for cerebrovascular and cardiovascular risk reduction.引言:依普罗沙坦的药理学特性——对降低脑血管和心血管风险的意义。
Curr Med Res Opin. 2007 Nov;23 Suppl 5:S1-3. doi: 10.1185/030079907X260692.
8
Costs of eprosartan versus diuretics for treatment of hypertension in a geriatric population: an observational, open-label, multicentre study.依普罗沙坦与利尿剂治疗老年人群高血压的成本比较:一项观察性、开放性、多中心研究。
Drugs Aging. 2009;26(7):617-26. doi: 10.2165/11316370-000000000-00000.
9
Observational Study on Cognitive function And systolic blood pressure Reduction (OSCAR): preliminary analysis of 6-month data from > 10,000 patients and review of the literature.认知功能与收缩压降低的观察性研究(OSCAR):对10000多名患者6个月数据的初步分析及文献综述
Curr Med Res Opin. 2007 Nov;23 Suppl 5:S13-8. doi: 10.1185/030079907X260719.
10
Eprosartan: a review of its use in the management of hypertension.依普罗沙坦:其在高血压治疗中的应用综述
Drugs. 2005;65(16):2355-77. doi: 10.2165/00003495-200565160-00012.

引用本文的文献

1
Diagnostic Challenges in Enteropathies: A Histopathological Review.肠病的诊断挑战:组织病理学综述
Diagnostics (Basel). 2025 Jun 13;15(12):1511. doi: 10.3390/diagnostics15121511.
2
Angiotensin Receptor Blockers Associated Enteropathy-Brief Report.血管紧张素受体阻滞剂相关性肠病——简要报告
J Community Hosp Intern Med Perspect. 2022 May 2;12(3):80-82. doi: 10.55729/2000-9666.1058. eCollection 2022.
3
Coeliac disease enteropathy and symptoms may be aggravated by angiotensin receptor blockers in patients on a gluten-free diet.
麸质无饮食患者的血管紧张素受体阻滞剂可能会加重乳糜泻肠病和症状。
United European Gastroenterol J. 2021 Oct;9(8):973-979. doi: 10.1002/ueg2.12117. Epub 2021 Jun 29.
4
Association of sprue-like enteropathy and angiotensin receptor-1 antagonists.肠病样吸收不良与血管紧张素受体拮抗剂的相关性。
Wien Klin Wochenschr. 2019 Oct;131(19-20):493-501. doi: 10.1007/s00508-019-01539-2. Epub 2019 Aug 30.
5
Angiotensin II receptor blockers and gastrointestinal adverse events of resembling sprue-like enteropathy: a systematic review.血管紧张素 II 受体阻滞剂与类口炎性腹泻样小肠病的胃肠道不良事件:一项系统评价
Gastroenterol Rep (Oxf). 2019 Jun;7(3):162-167. doi: 10.1093/gastro/goz019. Epub 2019 Jun 1.
6
Severe intestinal malabsorption associated with ACE inhibitor or angiotensin receptor blocker treatment. An observational cohort study in Germany and Italy.与ACE抑制剂或血管紧张素受体阻滞剂治疗相关的严重肠道吸收不良。德国和意大利的一项观察性队列研究。
Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):581-586. doi: 10.1002/pds.4402. Epub 2018 Feb 19.
7
Telmisartan-induced sprue-like enteropathy: a case report and a review of patients using non-olmesartan angiotensin receptor blockers.替米沙坦诱发的口炎性腹泻样小肠病:一例病例报告及对使用非奥美沙坦类血管紧张素受体阻滞剂患者的文献综述
Intest Res. 2017 Jul;15(3):419-421. doi: 10.5217/ir.2017.15.3.419. Epub 2017 Jun 12.
8
Olmesartan-induced Enteropathy Manifesting as Wernicke-Korsakoff Syndrome.奥美沙坦诱发的肠病表现为韦尼克-科尔萨科夫综合征。
Intern Med. 2016;55(24):3675-3678. doi: 10.2169/internalmedicine.55.7388. Epub 2016 Dec 15.